Modified Nucleosides
2',3'-Dideoxy-2',3'-didehydroinosine
Quick view. We supply 2',3'-Dideoxy-2',3'-didehydroinosine as a specialty product for nucleic acid chemistry and oligonucleotide research workflows. CAS 42867-68-5. Catalog target purity: Specification on request.
Product profile
2',3'-Dideoxy-2',3'-didehydroinosine is classified as nucleoside or protected nucleoside intermediate (Formula C10H10N4O3; molecular weight 234.21).
2',3'-Dideoxy-2',3'-didehydroinosine can serve as a starting material, protected intermediate or analytical comparator in nucleoside and nucleotide route development.
For 2',3'-Dideoxy-2',3'-didehydroinosine, storage: 2-8°C.
Names and search terms
Confirmed or normalized name variants
- D4I
- Didanosine EP Impurity F
- 2’,3’-Didehydrodidanosine
- Didanosine EP Impurity F Sodium Salt
- 2',3'-DIDEHYDRO-2',3'-DIDEOXYINOSINE
- Inosine, 2',3'-didehydro-2',3'-dideoxy-
- 2',3'-Dideoxy-2',3'-didehydro-inosine sodium
- 2',3'-DIDEOXY-2',3'-DIDEHYDROINOSINE 42867-68-5
Useful catalog search terms
- CAS 42867-68-5
- Nucleoside or protected nucleoside intermediate
- Modified Nucleosides
Physicochemical data
| InChI | InChI=1S/C10H10N4O3/c15-3-6-1-2-7(17-6)14-5-13-8-9(14)11-4-12-10(8)16/h1-2,4-7,15H,3H2,(H,11,12,16)/t6-,7+/m0/s |
|---|---|
| InChIKey | TYQPBHYPIRLWKU-NKWVEPMBSA-N |
| SMILES | C1=C[C@@H](O[C@@H]1CO)N2C=NC3=C2NC=NC3=O |
| Boiling point | 666.3±55.0 °C(Predicted) |
| Density | 1.74±0.1 g/cm3(Predicted) |
| pKa | 8.92±0.70(Predicted) |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Additional application examples
- Typical work includes protection/deprotection studies, phosphorylation or phosphitylation route scouting and impurity identification.
- The material can support medicinal-chemistry analog preparation and process-development feasibility studies.
Product-specific evaluation notes
Potential advantages
- Dideoxy analogs provide clear extension-stop behavior when accepted by a polymerase.
Method limitations
- Polymerase acceptance varies; absence of a 3′-OH prevents further extension after incorporation.
These points describe 2',3'-Dideoxy-2',3'-didehydroinosine or its named chemical feature. Broader product-family guidance is maintained on the category page.
Related products
(S)-cEt-rA
Modified Nucleosides · CAS: 1197033-34-3
BX-OP-0069S-Adenosylmethionine (SAM)
Modified Nucleosides · CAS: 485-80-3
BX-MN-0185(R-/S-) 5-Carbamoylhydroxy methyluridine
Modified Nucleosides · CAS: N/A
BX-MN-0186(R-/S-)5-(1-Hydroxy)(methoxycarbonyl)methyl uridine
Modified Nucleosides · CAS: N/A
BX-MN-0187(R-/S-)5-Carboxyhydroxymethyl uridine
Modified Nucleosides · CAS: N/A
BX-MN-0719(R)-N-(2,3-dihydro-1H-indenyl)adenosine
Modified Nucleosides · CAS: 96392-15-3
Frequently asked questions
Can the package size for 2',3'-Dideoxy-2',3'-didehydroinosine be customized?
Yes. Share the initial quantity, expected future scale, delivery timeline and packaging preference for review.
What information should be included in a quote request?
Quote catalog number BX-MN-0532 and CAS 42867-68-5, the intended research workflow, required quantity and any additional HPLC, MS or NMR documentation needed.
Product-family literature
The publications below provide peer-reviewed context for the Modified Nucleosides product family and its named chemistry.
